ZIHIPP
Zihipp is a biotechnology company. They offer services that include weight loss therapies for the treatment of obesity and diabetes. They offer services for women, adults, and men.
ZIHIPP
Social Links:
Industry:
Health Care
Founded:
2012-12-24
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.zihipp.com
Total Employee:
1+
Status:
Active
Total Funding:
3.3 M GBP
Similar Organizations
Ascensia Diabetes Care
Ascensia Diabetes Care is a global company dedicated to improving the health and lives of people with diabetes.
Cecelia Health
Cecelia Health is a health-tech company that connects clinical coaching and proprietary technology with people living with diabetes.
GOLO
GOLO provides a lifestyle solution that creates safe, sustainable weight loss by addressing insulin resistance.
Infervision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
Mirvie
Mirvie is a biotech company that creates precise, actionable, and non-invasive tests for maternal-fetal health.
ProNoto
ProNoto is an information technology company that provides peer curated content for physicians, researchers, and clinicians.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Strados Labs
Strados Labs innovates respiratory monitoring using smart biosensors and artificial intelligence.
Vitauthority
Vitauthority is a seller of health and nutrition products.
Current Employees Featured
Official Site Inspections
http://www.zihipp.com
- Host name: 172.67.196.139
- IP address: 172.67.196.139
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Zihipp"
Zihipp - Crunchbase Company Profile & Funding
Organization. Zihipp . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Zihipp is developing satiety hormone analogues, …See details»
Zihipp Limited - The Org
Zihipp is a UK based biotechnology company developing safe and effective weight loss therapies for the treatment of obesity and diabetes that deliver the benefits of gastrointestinal surgery …See details»
Zihipp Company Profile 2024: Valuation, Investors, Acquisition
Zihipp General Information Description. Operator of a biotechnology company intended to develop weight loss therapies. The company develops novel treatments for metabolic disorders, …See details»
Zihipp Company Profile | Management and Employees List
Zihipp will use the funds to develop a pipeline of oxyntomodulin and PYY peptides originating in the laboratory of Professor Sir Stephen Bloom FRS at Imperial College London. Zihipp …See details»
Zihipp - Products, Competitors, Financials, Employees, …
Zihipp is a biotechnology company focused on developing therapies for obesity and metabolic diseases. The company's main offerings include safe and effective weight loss therapies and …See details»
ZIHIPP LTD Company Profile | BRISTOL, United Kingdom
Zihipp ltd. d&b business directory home / business directory / professional, scientific, and technical services / scientific research and development services / united kingdom / bristol / zihipp ltd; …See details»
Zihipp Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Nov 1, 2024 At the top was a UK startup called Zihipp, which had a library of 20,000 peptides, or a “Lego kit for weight loss and diabetes” and a toehold in the clinic, Meanwell said. Its founder, …See details»
Zihipp - Company Profile - Tracxn
Nov 5, 2024 Zihipp - Developer of drugs for obesity and diabetes treatment. Raised a total funding of $4.3M over 1 round from 1 investor. Zihipp has 282 competitors.See details»
Zihipp - Funding, Financials, Valuation & Investors - Crunchbase
Zihipp is a healthcare company that assists in losing weight and treating weight gain caused by diabetes. Search Crunchbase. Start Free Trial . Chrome Extension. ... How much funding has …See details»
Zihipp - Contacts, Employees, Board Members, Advisors & Alumni
Zihipp is a healthcare company that assists in losing weight and treating weight gain caused by diabetes.See details»
Metsera
Empowering Consumers Our vision is that healthy, sustainable weight loss can be empowering. Trusted medicines, technologies and joined-up support can optimize weight management and …See details»
UAE-backed UK biotech firm Zihipp takes aim at global obesity
Sep 17, 2021 Professor Sir Stephen Bloom, executive chairman of Zihipp, hopes the drug will combat the global obesity 'tsunami'. Mark Chilvers for The National. Business. Future. UAE …See details»
EOFlow and Zihipp Announce Joint Venture for Development of …
Dec 28, 2021 Zihipp is a UK biotech firm which spun out from Imperial College London in 2012. ... According to the World Health Organization (WHO) and International Association for the …See details»
NEWS - EOFLOW
According to the World Health Organization (WHO) and International Association for the Study of Obesity (IASO), in 2016, more than 1.9 billion adults, 18 years or older, were overweight and …See details»
EOFlow and Zihipp Announce Joint Venture for Development of …
Dec 28, 2021 Zihipp is a UK biotech firm which spun out from Imperial College London in 2012. ... According to the World Health Organization (WHO) and International Association for the …See details»
NEWS - EOFLOW
Zihipp, a spin out from Imperial College London, is led by highly respected Prof. Sir Stephen R. Bloom who is well known as a seminal figure in creation of the hormone-based diabetes and …See details»
EOFlow, Zihipp establish joint venture in US for obesity, NASH
Dec 28, 2021 The World Health Organization (WHO) and International Association for the Study of Obesity (IASO) data showed that more than 1.9 billion people older than 18 were …See details»
Zihipp Ltd. (Zihipp Ltd.) - 药物管线_专利_临床试验_投融营收
Meanwell and Burow went after both, founding Metsera while acquiring Zihipp and licensing assets from D&D. With $290 million in funding, Metsera is now focused on bringing a few …See details»
Metsera lands with $290m to take on obesity giants
Apr 19, 2024 The candidates all stem from Metsera’s takeover of London, UK-based biotech Zihipp, a specialist in gastrointestinal hormones, with a proprietary library of more than 20,000 …See details»
EOFlow和Zihipp成立治疗肥胖合资公司 - CHINAGUT
2021 年 12 月 28 日，穿戴式药物递送解决方案供应商 EOFlow 宣布与英国生物科技初创企业 Zihipp 成立合资企业。 新企业命名为 SanPlena，将专注于开发一系列肠源激素（Gut …See details»